RecallRadar

FDA Drug recall D-0003-2022

Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydr…

On 2021-10-13 the FDA classified a Class I recall of Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydr… by Azurity Pharmaceuticals, citing product Mix-up: Incorrect diluent component included in the kit.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0003-2022
ClassificationClass I
Statusterminated
Initiated2021-08-24
Published2021-10-13
Last updated2026-09-13 11:52 UTC
CompanyAzurity Pharmaceuticals
DistributionUS

Product

Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle containing 145 mL Grape Flavored Diluent for reconstitution per carton, Rx only, Manufactured for: Azurity pharmaceuticals, Wilmington, MA 01887, NDC 65628-206-05.

Reason

Product Mix-up: Incorrect diluent component included in the kit.

Identifiers

ndc65628-204-05
ndc65628-205-10
ndc65628-206-05
ndc65628-208-10
code_infoLot # 21035, Exp 7/31/2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0003-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.